Pharmaceutical Analysis & Statistics in Oceania Countries, January 2014 (p5)

121-150 of about 200 reports

Purchase Reports From Reputable Market Research Publishers

BioDiem Ltd - Product Pipeline Review - 2014

BioDiem Ltd - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • January 2014
  • by Global Markets Direct

BioDiem Ltd - Product Pipeline Review - 2014 Summary Global Market Direct’s pharmaceuticals report, “BioDiem Ltd - Product Pipeline Review - 2014” provides data on the BioDiem Ltd’s research and ...

  • Industries : Biopharmaceutical, Pathology, Drug and Medication, Research and Development, Pharmaceutical
  • Countries : Australia, World, United States
Drug Stores and Health and Beauty Stores in New Zealand: Market Snapshot to 2017

Drug Stores and Health and Beauty Stores in New Zealand: Market Snapshot to 2017

  • $ 75
  • Industry report
  • January 2014
  • by Canadean Ltd

Synopsis Canadean’s, "Drug Stores and Health and Beauty Stores in New Zealand: Market Snapshot to 2017" contains detailed historic and forecast retail sales values of New Zealand Drug Stores and Health ...

  • Industries : Retail, Pharmacies and Drug Stores, Pharmacies and Personal Care Stores
  • Countries : New Zealand
Orphan Australia Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Orphan Australia Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • January 2014
  • by Global Data

Summary Orphan Australia Pty Ltd (Orphan Australia) is a pharmaceutical company. The company provides novel therapies for the treatment of serious or life-threatening diseases in Australia and New Zealand. ...

  • Industries : Pharmaceutical
  • Countries : Australia
Sigma Pharmaceuticals Limited - Strategy and SWOT Report

Sigma Pharmaceuticals Limited - Strategy and SWOT Report

  • $ 175
  • Company report
  • January 2014
  • by MarketLine

Sigma Pharmaceuticals Limited - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service ...

  • Industries : Pharmaceutical
  • Countries : Australia
Pharmaceuticals in Australia: ISIC 2423

Pharmaceuticals in Australia: ISIC 2423

  • $ 599
  • Industry report
  • January 2014
  • by Euromonitor International

Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to the size and shape of the Pharmaceuticals market at ...

  • Industries : Pharmaceutical
  • Countries : Australia
Drug Stores and Health and Beauty Stores in Australia: Market Snapshot to 2017

Drug Stores and Health and Beauty Stores in Australia: Market Snapshot to 2017

  • $ 75
  • Industry report
  • December 2013
  • by Canadean Ltd

Synopsis Canadean’s, "Drug Stores and Health and Beauty Stores in Australia: Market Snapshot to 2017" contains detailed historic and forecast retail sales values of Australia Drug Stores and Health and ...

  • Industries : Specialty Stores, Pharmacies and Drug Stores, Pharmacies and Personal Care Stores
  • Countries : Australia
Psychiatric Hospitals in Australia - Industry Market Research Report

Psychiatric Hospitals in Australia - Industry Market Research Report

  • $ 965
  • Industry report
  • December 2013
  • by Ibisworld

Stable condition: Industry grows despite shift towards community-based treatments Psychiatric Hospitals in Australia This industry consists of hospitals that primarily provide specialist psychiatric ...

  • Industries : Medical Facility, Healthcare
  • Countries : Australia
Therapy Class Overview : Hepatitis C Virus Infection

Therapy Class Overview : Hepatitis C Virus Infection

  • $ 1 000
  • Industry report
  • October 2013
  • by MP Advisors

Freedom from injecting Interferon (IFN), treating major HCV genotypes WW and betting on vaccines could bring a sea of change in the treatment of HCV infection in the future. This year the first IFN-free ...

  • Industries : Drug and Medication
  • Countries : Asia, Australia, China, Taiwan, World, Vietnam, India, Pakistan, Egypt, Saudi Arabia, Syrian Arab Republic
Menomune (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

Menomune (Meningococcal Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • September 2013
  • by Global Data

Menomune (Meningococcal Vaccines) - Forecast and Market Analysis to 2022 Summary Meningococcal disease is an acute infection caused by the gram-negative bacterium Neisseria meningitidis. Its rapid onset ...

  • Industries : Drug and Medication
  • Countries : Australia, World
OTC Pharmaceuticals in Australia

OTC Pharmaceuticals in Australia

  • $ 350
  • Industry report
  • August 2013
  • by MarketLine

Introduction OTC Pharmaceuticals in Australia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2008-12, and forecast ...

  • Industries : Over-The-Counter Drug, Drug and Medication, Pharmaceutical
  • Countries : Australia
Celesio AG : Retail - Company Profile, SWOT and Financial Report

Celesio AG : Retail - Company Profile, SWOT and Financial Report

  • $ 125
  • Company report
  • August 2013
  • by Canadean Ltd

Synopsis Canadean's "Celesio AG : Retail - Company Profile, SWOT and Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overview, ...

  • Countries : Europe, Australia
OTC Triptans in New Zealand

OTC Triptans in New Zealand

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

During 2012 there were only two OTC triptan products available in New Zealand, Sumagran Active (Mylan New Zealand) and Zomig (AstraZeneca). Several other prescription products were available, such as Maxalt ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Ear Care in New Zealand

Ear Care in New Zealand

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

Ear care value sales increased by 2% in 2012, which is lower than the 2011 growth of 33%. This is also compared with the current value review period CAGR of 8%. Higher growth in 2011 and over the review ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Emergency Contraception in New Zealand

Emergency Contraception in New Zealand

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

Emergency contraception continued to be an acceptable medical method of preventing pregnancy within New Zealand during 2012. While abortion services are provided for free within New Zealand for permanent ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Eye Care in New Zealand

Eye Care in New Zealand

  • $ 898
  • Industry report
  • July 2013
  • by Euromonitor International

Current retail value growth of 3% in 2012 was below the review period current value CAGR of 4%. Value sales for allergy and standard eye care increased by 3% during 2012. However, the current value review ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Douglas Pharmaceuticals Ltd in Consumer Health (New Zealand)

Douglas Pharmaceuticals Ltd in Consumer Health (New Zealand)

  • $ 153
  • Company report
  • July 2013
  • by Euromonitor International

By focusing on low-volume high-value products, Douglas Pharmaceuticals continues to attract consumers and expand its operations. Douglas Pharmaceuticals focuses on generic as well as difficult to manufacture ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
Mylan New Zealand Ltd in Consumer Health (New Zealand)

Mylan New Zealand Ltd in Consumer Health (New Zealand)

  • $ 153
  • Company report
  • July 2013
  • by Euromonitor International

Over the forecast period Mylan New Zealand Ltd will focus on its core business of manufacturing and distributing pharmaceutical prescription and OTC consumer health products. Euromonitor International ...

  • Industries : Healthcare, Pharmaceutical
  • Countries : New Zealand
ICT budget forecasts in Medium-sized New Zealand Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

ICT budget forecasts in Medium-sized New Zealand Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

  • $ 495
  • Industry report
  • July 2013
  • by Kable

Synopsis This report illustrates how Kable expects Medium-sized New Zealand Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
ICT budget forecasts in Small New Zealand Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

ICT budget forecasts in Small New Zealand Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

  • $ 495
  • Industry report
  • July 2013
  • by Kable

Synopsis This report illustrates how Kable expects Small New Zealand Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
ICT budget forecasts in Large New Zealand Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

ICT budget forecasts in Large New Zealand Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

  • $ 495
  • Industry report
  • July 2013
  • by Kable

Synopsis This report illustrates how Kable expects Large New Zealand Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
ICT budget forecasts in Small Australian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

ICT budget forecasts in Small Australian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

  • $ 495
  • Industry report
  • July 2013
  • by Kable

Synopsis This report illustrates how Kable expects Small Australian Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, ...

  • Industries : Pharmaceutical
  • Countries : Australia
ICT budget forecasts in Large Australian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

ICT budget forecasts in Large Australian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

  • $ 495
  • Industry report
  • July 2013
  • by Kable

Synopsis This report illustrates how Kable expects Large Australian Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, IT services, ...

  • Industries : Pharmaceutical
  • Countries : Australia
ICT budget forecasts in Medium-sized Australian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

ICT budget forecasts in Medium-sized Australian Pharmaceutical Companies - Estimated ICT budget breakdowns in 2013

  • $ 495
  • Industry report
  • July 2013
  • by Kable

Synopsis This report illustrates how Kable expects Medium-sized Australian Pharmaceutical Companies to allocate their ICT budgets across the core areas of enterprise ICT spend, namely hardware, software, ...

  • Industries : Pharmaceutical
  • Countries : Australia
Australian Pharmaceutical Industries Ltd in Retailing (Australia)

Australian Pharmaceutical Industries Ltd in Retailing (Australia)

  • $ 153
  • Company report
  • July 2013
  • by Euromonitor International

Australian Pharmaceutical Industries Ltd is planning for rapid expansion in Australia, with the aim of opening at least 400 Priceline stores by 2014. This target amounts to an expansion of up to 50% from ...

  • Industries : Pharmaceutical
  • Countries : Australia
iNova Pharmaceuticals (Australia) Pty Limited - Strategic SWOT Analysis Review

iNova Pharmaceuticals (Australia) Pty Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • July 2013
  • by Global Data

Summary This comprehensive SWOT profile of iNova Pharmaceuticals (Australia) Pty Limited provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give ...

  • Countries : Australia
Australian Pharmaceutical Industries Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Australian Pharmaceutical Industries Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : Australia
New Zealand Pharmaceuticals Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

New Zealand Pharmaceuticals Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : New Zealand
Pharmacybrands Ltd in Retailing (New Zealand)

Pharmacybrands Ltd in Retailing (New Zealand)

  • $ 153
  • Company report
  • May 2013
  • by Euromonitor International

Pharmacybrands is expected to continue expanding its network of chemists/pharmacies across New Zealand through its five fascias; Amcal, Care Chemist, Radius Pharmacy, Life Pharmacy and Unichem. The company ...

  • Industries : Pharmacies and Drug Stores
  • Countries : New Zealand
EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022

EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • May 2013
  • by Global Data

EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022 Summary Meningococcal disease is caused by Neisseria meningitidis, which is an encapsulated, Gram-negative bacterium that has an incidence ...

  • Industries : Pathology
  • Countries : World, Spain, United Kingdom, Australia, Brazil
iNova Pharmaceuticals (Australia) Pty Ltd in Consumer Health (Australia)

iNova Pharmaceuticals (Australia) Pty Ltd in Consumer Health (Australia)

  • $ 153
  • Company report
  • March 2013
  • by Euromonitor International

iNova Pharmaceuticals (Australia) Pty Ltd is focusing on acquiring products and distribution rights to continue its expansion in Australia and in the export markets of New Zealand, the Asia-Pacific region ...

  • Industries : Pharmaceutical
  • Countries : Australia

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.